Cisco very happy with 82% effective diognoses rate for iT Bra vs 42% using traditional breast cancer tech on dense breast tissue. Look for some noise from Cisco later this year, when the product distribution begins in Asha, land of the dense breast tissue market. (Preliminary breast tumor “blood”test Only 33% effective, and a very long way until market rollout 5-6-7 yrs???)